相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Successful Expansion but Not Complete Restriction of Tropism of Adeno-Associated Virus by In Vivo Biopanning of Random Virus Display Peptide Libraries
Stefan Michelfelder et al.
PLOS ONE (2009)
A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selection
Lin Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses
Dirk Grimm et al.
JOURNAL OF VIROLOGY (2008)
Engineering and selection of shuffled AAV genomes: A new strategy for producing targeted biological nanoparticles
Wuping Li et al.
MOLECULAR THERAPY (2008)
DNA shuffling of adeno-associated virus yields functionally diverse viral progeny
James T. Koerber et al.
MOLECULAR THERAPY (2008)
Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection
Carmela Zincarelli et al.
MOLECULAR THERAPY (2008)
Isolation of targeted AAV2 vectors from novel virus display libraries
Daniel A. Waterkamp et al.
JOURNAL OF GENE MEDICINE (2006)
Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo
Christina A. Pacak et al.
CIRCULATION RESEARCH (2006)
Metabolic biotinylation provides a unique platform for the purification and targeting of multiple AAV vector serotypes
Gregory S. Arnold et al.
MOLECULAR THERAPY (2006)
Robust systemic transduction with AAV9 vectors in mice: Efficient global cardiac gene transfer superior to that of AAV8
Katsuya Inagaki et al.
MOLECULAR THERAPY (2006)
Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer
Brian D. Brown et al.
NATURE MEDICINE (2006)
A hybrid vector for ligand-directed tumor targeting and molecular imaging
A Hajitou et al.
CELL (2006)
Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors
OJ Müller et al.
CARDIOVASCULAR RESEARCH (2006)
Combinatorial engineering of a gene therapy vector:: directed evolution of adeno-associated virus
L Perabo et al.
JOURNAL OF GENE MEDICINE (2006)
Directed evolution of adeno-associated virus yields enhanced gene delivery vectors
N Maheshri et al.
NATURE BIOTECHNOLOGY (2006)
Transductional targeting of adenovirus vectors for gene therapy
J. N. Glasgow et al.
CANCER GENE THERAPY (2006)
Sustained whole-body functional rescue in congestive heart failure and muscular dystrophy hamsters by systemic gene transfer
T Zhu et al.
CIRCULATION (2005)
Green fluorescent protein-tagged adeno-associated virus particles allow the study of cytosolic and nuclear trafficking
K Lux et al.
JOURNAL OF VIROLOGY (2005)
Transcriptionally targeted adenovirus vectors
H Sadeghi et al.
CURRENT GENE THERAPY (2005)
Altering AAV tropism with mosaic viral capsids
L Gigout et al.
MOLECULAR THERAPY (2005)
New recombinant serotypes of AAV vectors
GP Gao et al.
CURRENT GENE THERAPY (2005)
Custom adeno-associated virus capsids: The next generation of recombinant vectors with novel tropism
N Muzyczka et al.
HUMAN GENE THERAPY (2005)
Probing sequence variation in the receptor-targeting domain of feline leukemia virus envelope proteins with peptide display libraries
K Bupp et al.
JOURNAL OF VIROLOGY (2005)
Efficacy of an adeno-associated virus 8-pseudotyped vector in glycogen storage disease type II
BD Sun et al.
MOLECULAR THERAPY (2005)
Unrestricted hepatocyte transduction with adeno-associated virus serotype 8 vectors in mice
H Nakai et al.
JOURNAL OF VIROLOGY (2005)
Targeted gene delivery to vascular tissue in vivo by tropism-modified adeno-associated virus vectors
SJ White et al.
CIRCULATION (2004)
Development of efficient viral vectors selective for vascular smooth muscle cells
LM Work et al.
MOLECULAR THERAPY (2004)
Systemic delivery of genes to striated muscles using adeno-associated viral vectors
P Gregorevic et al.
NATURE MEDICINE (2004)
Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus
KH Warrington et al.
JOURNAL OF VIROLOGY (2004)
Clades of Adeno-associated viruses are widely disseminated in human tissues
GP Gao et al.
JOURNAL OF VIROLOGY (2004)
Genetic modifications of the adeno-associated virus type 2 capsid reduce the affinity and the neutralizing effects of human serum antibodies
NA Huttner et al.
GENE THERAPY (2003)
Identification of a heparin-binding motif on adeno-associated virus type 2 capsids
A Kern et al.
JOURNAL OF VIROLOGY (2003)
Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors
OJ Müller et al.
NATURE BIOTECHNOLOGY (2003)
Targeting recombinant adeno-associated virus vectors to enhance gene transfer to pancreatic islets and liver
SA Loiler et al.
GENE THERAPY (2003)
Receptor targeting of adeno-associated virus vectors
H Büning et al.
GENE THERAPY (2003)
In vitro selection of viral vectors with modified tropism:: The adeno-associated virus display
L Perabo et al.
MOLECULAR THERAPY (2003)
Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding
SR Opie et al.
JOURNAL OF VIROLOGY (2003)
Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6
D Grimm et al.
MOLECULAR THERAPY (2003)
RGD inclusion in VP3 provides adeno-associated virus type 2 (AAV2)-based vectors with a heparan sulfate-independent cell entry mechanism
WF Shi et al.
MOLECULAR THERAPY (2003)
Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo
Z Wang et al.
GENE THERAPY (2003)
Ligand-directed targeting of genes to the site of disease
Thomas J. Wickham
NATURE MEDICINE (2003)
Conjugate-based targeting of recombinant adeno-associated virus type 2 vectors by using avidin-linked ligands
S Ponnazhagan et al.
JOURNAL OF VIROLOGY (2002)
Development and optimization of a real-time quantitative PCR-Based method for the titration of AAV-2 vector stocks (vol 6, pg 272, 2002)
MR Veldwijk et al.
MOLECULAR THERAPY (2002)
Adeno-associated virus capsids displaying immunoglobulin-binding domains permit antibody-mediated vector retargeting to specific cell surface receptors
MU Ried et al.
JOURNAL OF VIROLOGY (2002)
Altering retroviral tropism using a random-display envelope library
K Bupp et al.
MOLECULAR THERAPY (2002)
Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors
WF Shi et al.
HUMAN GENE THERAPY (2001)
Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells
SA Nicklin et al.
MOLECULAR THERAPY (2001)
Incorporation of tumor-targeting peptides into recombinant adeno-associated virus capsids
M Grifman et al.
MOLECULAR THERAPY (2001)
Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism
P Wu et al.
JOURNAL OF VIROLOGY (2000)
分享论文
